From February of 2022, subscribers will be able to view and filter individual regulatory alerts per region. If you want to get our alerts compilations, visit our alerts Round-up section.
- United States Senator blocks bipartisan cannabis research bill…
- Paraguay Dinavisa updates the medical cannabis licence procedure…
- Iceland Bid to decriminalise cannabis possession for personal use…
- Panama Survey finds big opposition to recreational cannabis use…
- United Kingdom FSA rejects FOI request on CBD safety review…
- Australia Greens drawing up bill to legalise recreational cannabis…
- Italy Right-wing government spells bad news for cannabis…
- Brazil Medical cannabis cannot be sold through delivery services…
- Colombia President Petro urged to support bill on recreational cannabis…
- Arkansas - United States Votes will be counted in ballot measure to legalise recreational cannabis…
- Paraguay Discussion to improve availability of medicinal cannabis…
- Canada Legislative review of the Cannabis Act launched…
Panama: The National Institute of Statistics and Census (INEC) has published the results of a survey conducted in over 16,000 homes, which found only 7% approved of the recreational use of cannabis, with 88% opposed. Cannabis is currently allowed in Panama for medical purposes only.
UK: Hemp Today said today that the Food Standards Agency (FSA) had rejected a Freedom of Information request concerning companies whose products are under CBD safety assessment on the grounds that providing answers would increase the workload on its staff.
Australia: The Greens party intends to introduce a bill to legalise recreational cannabis, press reports. The party is currently drafting the bill, which it expects to introduce before the end of the year. Though the Greens have just four seats in the 151-seat House of Representatives and 12 in the 76-seat Senate, the bill is expected to have the support of other parties.
Italy: A hard-line stance against cannabis can be expected in Italy after the far-right Brothers of Italy party (Fratelli d’Italia) took first place in Sunday’s election with over 26% of the vote. The party, led by populist Giorgia Meloni, is likely to form a coalition with other right-wing parties, Forza Italia and the League – whose leader, Matteo Salvini, rejects the difference between “soft” and “hard” drugs and does not believe in the benefits of legalising or decriminalising adult-use cannabis.
Brazil: The National Public Health Surveillance Agency (Anvisa) has clarified that medical cannabis products cannot be sold through delivery services. Cannabis-derived products previously allowed by the agency must follow the rules for controlled drugs and can only be sold by pharmacies under prescription.
World: Jagjit Pavadia, president of the independent, quasi-judicial International Narcotics Control Board (INCB), told a meeting of the UN Commission on Narcotic Drugs yesterday that legalisation of recreational cannabis is a breach of international conventions, and a “threat to the consensus” on global drug control. In response, the representative from Canada, where recreational cannabis was legalised in 2018, defended the country’s policies and questioned the authority of the INCB to monitor treaty compliance by UN member states.
Spain: The General Council of Official Colleges of Pharmacists (CGCOF) wants greater assurances on the use of medical cannabis, press reports. CGCOF vice president Jordi de Dalmases Balañá told the National Congress of the Pharmaceutical Profession yesterday that “the use of active ingredients as medicines requires proven clinical evidence of quality, efficacy, and safety”. Carola Perez, president of the Spanish Observatory on Medical Cannabis, called for the legalisation and regulation of medical cannabis to be put in place more quickly.
US - Minnesota: Medical cannabis company Vireo Health has filed a lawsuit against the state alleging that House File (HF) 4065 – which allows the sale of hemp-derived edibles – unfairly discriminates against cannabis-derived edibles. According to the company, the hemp-derived edibles are chemically identical to their cannabis-derived medical edibles.
US - Oklahoma: The Oklahoma Supreme Court decided yesterday that the ballot initiative to legalise recreational cannabis in the state could not appear on the 8th November ballot because it had been delayed beyond the deadline for printing the papers, media reports. Justices dismissed two separate legal challenges to the ballot title, clearing the initiative’s path for a vote during the state’s next general or special election. Supporters of the measure say it will appear on the November ballot in 2024 at the latest, or sooner if the governor calls a special election.
Czech Republic: The Pirates party, liberal progressive members of the governing coalition, has presented a comprehensive analysis of the potential impacts of regulating the recreational cannabis market, including recommendations. According to Jana Michailida, head of the Pirates team on addictive behaviour, this is only an initial proposition for debate. The next step will be the detailed wording of the law. If it gets the backing of legislators, a regulated cannabis market could be launched in the Czech Republic in 2025.
US - New York: The Cannabis Control Board (CCB) has resolved to adopt revised regulations for the home cultivation of cannabis for medical use. Certified medical cannabis patients or designated caregivers will be able to harvest up to six plants, only three of which could be mature. The CCB has also approved amendments to the state's cannabinoid hemp program. Among other changes, the new rules create a licence for approved hemp farmers to sell flowers and raise the maximum cannabinoid allowance per individual serving to 100 mg. All the new rules will take effect on 5th October.
US - California: Governor Gavin Newsom has signed into law a number of new bills relating to cannabis. Assembly Bill 2188 prohibits employers, with a few exceptions, from discriminating against employees in hiring, termination, or any term or condition of employment for using cannabis while off the job. AB 1894 prohibits any indication on the packaging of cannabis vaporisers and cartridges that they are disposable and can be thrown away in trash or recycling streams, and requires specific labelling about their proper disposal.
US - California: Assembly Bill 1885, newly signed into law, expands the Medicinal and Adult-Use Cannabis Regulation and Safety Act to cover cannabis products intended for animals – other than livestock or food animals – and requires regulations for such products. Senate Bill 1186, also now law, prohibits localities from banning the retail sale by delivery of medical cannabis to qualified patients or their caregivers.
EU: The European Commission has published a draft delegated regulation amending Regulation (EC) No 1272/2008 on hazard classes and criteria for the classification, labelling and packaging of substances and mixtures (CLP). The amendment aims to update the CLP Regulation with new hazard classes and their criteria to take technical and scientific progress into account. This may impose new obligations on producers of e-cigarettes containing cannabis or hemp-derived products, covering more chemicals that may be contained in a device or delivery mechanism. The draft regulation is open until 18th October for comment, which will be taken into account in finalising the revised regulation.
Austria: Transport minister Leonore Gewessler, of the centre-left Green Party, is drawing up a bill to place a legal limit on THC for driving a vehicle, similar to the alcohol limit, press reports. She said: “According to the impairment principle, a distinction must be made between consumption that may have taken place days ago and present ability to drive. Clear criteria for this would also mean simplification of the testing procedure.” The ministry is currently looking at the procedures already being used in some other EU countries.
US - Nevada: A judge has ruled that the Nevada Board of Pharmacy may no longer list cannabis as a Schedule I drug, press reports. The American Civil Liberties Union (ACLU), which brought the lawsuit, claimed the Schedule I listing, despite voters passing an initiative in 2016 to legalise cannabis, created a loophole that allowed law enforcement to arrest people unjustly for cannabis offences.
US - federal: Representative Jared Huffman, a California Democrat, has introduced the Small and Homestead Independent Producers (SHIP) Act, which would allow small cannabis cultivators and manufacturers to operate and send their cannabis products across state lines directly to consumers. The bill is contingent, however, upon cannabis being removed from the federal Controlled Substances Act and federal criminal penalties for manufacturing and distributing cannabis being eliminated.
Thailand: The House of Representatives voted 198-136 to withdraw the Hemp and Cannabis Bill from the legislative agenda and return it to the drafting committee over concerns about allowing recreational cannabis use, media reports. Resistance to the bill came mostly from the opposition Pheu Thai party and the Democrat party, members of the ruling coalition, for not having enough controls to prevent recreational use besides banning public consumption. The opposition also objected to allowing the home cultivation of up to 15 plants. The bill may now be reintroduced in November.
Germany: Carmen Wegge, Social Democratic Party (SPD) spokesperson on cannabis legalisation, has told the newspaper Die Zeit that legalisation “will come” and “not fail due to EU law”. She said EU law was being taken into account in the process and that this was not news to Bundestag members.
US - Missouri: The Missouri Supreme Court declined to hear a lawsuit challenging a ballot initiative to legalise recreational cannabis, thereby clearing the final legal hurdles for the initiative to appear on the November ballot, press reports. Although the secretary of state had already validated the ballot initiative, a lawsuit challenged the validation process but was dismissed by lower courts.
Germany: Federal drugs commissioner Burkhard Blienert has retweeted the results of an Ipsos poll that found 61% of Germans support the full legalisation of cannabis. While 65% of 18-39 year-olds are in favour of legalisation, the figure falls to 55% among those aged 60-75.
US - West Virginia: A proposal to cap THC in medical cannabis products at 10% has been rejected by the Medical Cannabis Advisory Board – at least for the time being, press reports. The board said it needed more information before imposing any such cap. The board’s next meeting will be in January 2023.
US - Missouri: The Missouri Court of Appeals for the Western District has ruled that the signatures for a ballot initiative to legalise recreational cannabis were properly certified and that the initiative did not violate the state’s single-subject rule for ballot initiatives. The court therefore concluded that the initiative can appear on the ballot on 8th November.
Thailand: The Cannabis and Hemp Bill was presented to Parliament yesterday with a decision expected by 19th September, press reports. The bill would allow the home cultivation of up to 15 plants and would allow hospitals to grow cannabis for medicines listed in the Herbal Product Act.
UK - Scotland: The Scottish Medicines Consortium announced yesterday that Sativex was accepted for use within NHSScotland as treatment for relieving symptoms in adults with multiple sclerosis who have not responded adequately to other treatments.
Germany: The Bundestag Research Service, which produces non-partisan advice to politicians, has published a report stating that the planned legalisation of cannabis could conflict with EU legislation. A spokesperson for the Ministry of Health has told journalists that the issue of EU and international law will be addressed in a paper expected to be available in the autumn.
New Zealand: Two CBD liquids for oral use, Helius CBD25 Full Spectrum and Helius CBD100 Full Spectrum, have been verified by the Medical Cannabis Agency as meeting the minimum quality standard required for them to be supplied in New Zealand.